As per the Attachment

Ref. No.: CIAN/BSE/2026-27/16 Saturday, August 22, 2026 The Manager-Listing, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400 001 BSE Scrip Code: 542678 Trading Symbol: CHCL Subject: Disclosure pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) by Cian Healthcare Limited (“Company”). Reference: Disclosure dated December 19, 2025, in relation to the approval of the Resolution Plan by the Hon’ble NCLT vide its Order dated December 18, 2025, as submitted by the Successful Resolution Applicant (“SRA”), namely Mr. Pradeep Kumar Jain, under the relevant provisions of the Insolvency and Bankruptcy Code, 2016 (“Code”). Dear Sir/Ma’am, In compliance with the relevant provisions of Regulation 30 read with Schedule III, and other applicable provisions of the Listing Regulations, along with the provisions of SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (“SEBI Circular”), and in accordance with the relevant provisions of the Order of the Hon’ble National Company Law Tribunal dated December 18, 2025 (“NCLT Order”) read with the Resolution Plan approved therein and the trading approval for the 2,50,00,000 (Two Crores Fifty Lakhs) fully paid-up equity shares, from the BSE Limited (“BSE”) bearing a reference no. DCS/AMAL/AK/4144/2025-26 dated March 30, 2026, the Company hereby inform that the BSE, vide its notice bearing a reference no. 20260821-30 dated August 21, 2026, has revised the market lot size from 2,000 (Two Thousand) (as initially mentioned in the trading approval) to 137 (One Hundred Thirty Seven) fully paid-up equity shares, effective from Monday, August 24, 2026 A copy of the Notice received from the BSE is enclosed herewith as Annexure-A. Kindly take the above information on record and oblige. Thanking you, For Cian Healthcare Limited Rachit Malhotra Company Secretary and Chief Compliance Officer Membership No.: A39894 Place: Delhi Annexure-A NOTICE Notice No. 20260821-30 Notice Date 21 Aug 2026 Category Company related Segment Equity Department Listing Operations Subject Revision in lot size of Cian Healthcare Ltd. Attachments No Attachment This is in continuation to the Exchange notice no. 20260330-22 dated March 30, 2026, for recommencement of trading of Cian Healthcare Ltd. (Scrip Code- 542678). In this regard, trading members are hereby informed that the contents of the aforesaid notice remain unchanged, except for the revision in the market lot size as set out below, pursuant to the ratio mentioned in the Hon’ble NCLT Order dated December 18, 2025. Company Name Scrip Code Present Market Lot Revised Market Lot Cian Healthcare Ltd 542678 2000 137 The revision in the aforesaid lot size shall be e(cid:431)ective from August 24, 2026. This is for your information and record. Janardhan Wagle Tanmayi Lele Deputy Vice President Deputy Manager